申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2015180612A1
公开(公告)日:2015-12-03
Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
揭示了新型视黄醇相关孤儿受体γ(RORγ)调节剂及其在通过RORγ介导的疾病治疗中的应用。